With over a decade of research experience across Europe, I have dedicated my career to understand the molecular mechanisms behind cellular migration, tumor metabolism, and oncogenic signaling, while also developing novel therapeutic strategies. My doctoral research focused into the effects of mutant p53 proteins on metabolic pathways, significantly advancing our understanding of chemoresistance and tumor progression. I subsequently investigated potential therapies for specific cancer types and led the development of innovative nanomaterials for nucleic acid delivery to cancer cells. My recent work has explored metabolic plasticity in cancer, uncovering important insights into the role of oncogenic biomarkers in the autophagy process. Currently, at Complutense University of Madrid, I am focused on analyzing the impact of mutant p53 on therapy responses and elucidating the mechanisms involved. Additionally, I am developing personalized therapies that target critical oncogenic signaling pathways.

CNIC